ArticleJTO clinical and research reports2022

Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report.

Yuanbin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.